SpIntellx Appoints Industry Leader B. Dusty Majumdar, Ph.D. as Chief Executive Officer to Spearhead the Next Phase of Growth
PITTSBURGH, May 16, 2022 /PRNewswire-PRWeb/ -- B. Dusty Majumdar, Ph.D. has been appointed as the Chief Executive Officer (CEO) of SpIntellx, Inc., a Precision Pathology company whose mission is focused on dramatically improving patient outcomes fueled by proprietary unbiased spatial analytics and explainable AI. Dr. Majumdar, is a seasoned leader in Precision Healthcare with more than 20 years of experience in building and successfully launching innovative technologies across diagnostic imaging, oncology, multi-omics, Real-World Evidence (RWE) and liquid biopsy platforms leveraging some of the industry's most advanced AI platforms, genomic and clinical simulations (digital twins), and emerging medical imaging technologies.
- Dusty Majumdar, Ph.D. has been appointed as the Chief Executive Officer (CEO) of SpIntellx, Inc., a Precision Pathology company whose mission is focused on dramatically improving patient outcomes fueled by proprietary unbiased spatial analytics and explainable AI.
- "SpIntellx has made great progress in the last five years in Precision Pathology since its formation.
- SpIntellx offers software as a service (SaaS) for precision pathology applications harnessing unbiased spatial analytics and explainable AI.
- SpIntellx is completing a convertible note that will convert into the Series A that is planned for later this year.